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Abstract
Background: Although visceral pain of gastrointestinal (GI) origin is the major complaint in patients with irritable bowel
syndrome (IBS) it remains poorly understood. Brain imaging studies suggest a defect in brain-gut communication in IBS with
a greater activation of central arousal circuits including the amygdala. Previously, we found that stereotaxic implantation of
corticosterone (CORT) onto the amygdala in rats induced anxiety and colonic hypersensitivity. In the present study we used
functional magnetic resonance imaging (fMRI) to identify specific brain sites activated in a rat model characterized by
anxiety and colonic hypersensitivity.
Methodology/Principal Findings: Anesthetized male rats received micropellets (30 mg each) of either CORT or cholesterol
(CHOL), to serve as a control, implanted stereotaxically on the dorsal margin of each amygdala. Seven days later, rats were
anesthetized and placed in the fMRI magnet (7T). A series of isobaric colorectal balloon distensions (CRD - 90s ‘off’, 30s ‘on’,
8 replicates) at two pressures (40 and 60 mmHg) were performed in a standard block-design. Cross correlation statistical
analysis was used to determine significant differences between distended and non-distended states in CORT and CHOL-
treated animals. Analysis of the imaging data demonstrated greater overall brain activation in response to CRD in rats with
CORT implants compared to CHOL controls. Additionally, CORT implants produced significant positive bilateral increases in
MRI signal in response to CRD in specific nuclei known as integration sites important in anxiety and pain perception.
Conclusions and Significance: These data indicate that chronic exposure of the amygdala to elevated levels of CORT
enhances overall brain activation in response to CRD, and identified other specific brain regions activated in response to
mechanical distension of the colon. These results demonstrate the feasibility of performing fMRI imaging in a rodent model
that supports clinical observations in IBS patients with enhanced amygdala activation and symptomatology of abdominal
pain and anxiety.
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Introduction
The role of the brain in the processing of information from the
viscera, including the gastrointestinal (GI) tract, remains poorly
understood. Clinical observations suggest that episodes of stress
worsen symptoms associated with irritable bowel syndrome (IBS),
a functional GI disorder characterized by episodes of abdominal
pain, diarrhea and/or constipation and there is a close overlap
between IBS and anxiety disorders [1–4]. Studies in patients with
IBS suggest that heightened pain sensation to intraluminal
distension of the colorectum may play a significant role in IBS
symptomatology [5–7]. Altered perception of visceral stimuli due
to afferent sensitization can occur due to abnormalities in
ascending visceral signal processing from the gut to the brain
[8,9]. In addition, activation of central mechanism(s) resulting in
colorectal hypersensitivity due to descending facilitation from the
brain induces remodeling of colorectal responsiveness to distension
and involves activation of supraspinal nuclei leading to sensitiza-
tion of spinal dorsal horn neurons [10–13]. Clinically, activation of
descending facilitatory pathways may play a role in the
exacerbation of IBS symptoms in response to stress and anxiety
[14,15]. The amygdala, as part of the limbic system, is involved in
the processing of visceral information, attention, emotion and
integrating the physical and psychological components of the stress
response. Additionally, the amygdala plays a crucial role in the
generation and development of fear and anxiety [16,17].
Specifically, the central nucleus of the amygdala (CeA) has been
shown to facilitate the activation of the hypothalamic-pituitary-
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corticotrophin releasing factor, adrenocorticotropic hormone, and
corticosterone (CORT) [18,19]. The CeA is also a major source of
efferent pathways from the amygdala [20], and electrical
stimulation of the CeA has been shown to modulate cardiovascular
[21], respiratory [22], and GI function [5].
In recent years to investigate how the brain controls the GI
tract, imaging studies using both functional magnetic resonance
imaging (fMRI) and positron emission tomography have demon-
strated that, in IBS patients, colorectal distension (CRD) activates
areas of the brain involved in emotional sensory processing,
particularly the amygdala, insula, and prefrontal cortex [23–25].
Although fMRI is a powerful tool for noninvasive imaging of brain
function studies, neuroimaging in small animals such as rats are
limited. However, brain imaging in rodent models offer many
advantages such as being able to track the course of a diseases and
examine the efficacy of novel treatments with control over relevant
factors and experimental conditions that are uncontrollable in
human studies. Previous studies to examine brain-gut communi-
cation and visceral pain pathways have used techniques ranging
from electrophysiology [26–28] and c-fos detection [29–31] to
behavioral analyses [32,33]. One study using fMRI was able to
detect brain areas activated by distension of the colorectal region
in normal adult anesthetized rats [30]. The aim of our study was to
use MRI signal to investigate the effect on supraspinal neuronal
processing of manipulation of the amygdala via exposure to
elevated levels of CORT shown previously to induce anxiety-like
behaviors and increase the sensitivity of the colorectum to luminal
distension after 7 days. Blood oxygenation level dependent
(BOLD) fMRI in the brain was measured using T2
*-weighted fast
low angle shot (FLASH) imaging at 7T and was performed before,
during and after CRD in rats with micropellet implants of CORT
or cholesterol (CHOL) as a control. To our knowledge this is the
first study to image specific brain regions in response to a defined
manipulation of the amygdala in an animal model that mimics
aspects of IBS and is characterized by heightened anxiety and
abdominal pain. Our results showed that there are significant
differences in brain activation in rats in response to modulation of
the amygdala via elevated levels of CORT. These results
complement recent studies from our group and support clinical
observations in which abnormalities in amygdala activation
appear common in IBS patients [24,32,34].
Results
Effect of CRD on Total CNS Activation in Rats with
Elevated Levels of Amygdala CORT
Initially we investigated whether repetitive CRD at 40 mmHg
and 60 mmHg causes any disruption of the colonic mucosa. In this
part of the study we used the same experimental design as that
employed in the fMRI investigation, and examined the histological
appearance of the colonic mucosa from rats that underwent CRD
and compared the findings to naı ¨ve rats. Our results showed that 8
cycles of CRD at 40 mmHg and then 8 cycles at 60 mmHg caused
no significant alteration in the architecture of the colonic mucosa
compared to naı ¨ve controls (Figure 1) in any colonic region
examined and confirmed that there was no change in the
histological score between control and treated rats (Score=0 for
both groups in all regions).
In the current study we investigated total brain activation in
response to 40 and 60 mmHg of CRD in anesthetized rats with
bilateral implants of CORT placed stereotaxically on the dorsal
margin of the amygdala (Figure 2). At 40 mmHg, CRD induced
increases in CNS activation in control rats as illustrated in
Figure 3A. The data also showed increases in the total number of
activated pixels in CORT-implanted rats in response to CRD at
40 mmHg (Figure 3B). At a higher distension pressure of
60 mmHg there was an additional increase in the total number
of activated pixels in CHOL controls (Figure 4A). The 60 mmHg
CRD pressure also induced more total brain activation in rats with
CORT implants (Figure 4B). A careful comparison of the average
number of fMRI activated pixels between the 4 groups (CHOL,
40 mmHg – 28.2614.3 pixels or 60 mmHg – 173.0675.4 pixels
vs. CORT, 40 mmHg – 201.8682.3 or 60 mmHg – 317.06115.5
pixels, n=6 per group) indicated a significant effect of group (2-
Way ANOVA, F=4.442, P,0.05) and pressure (2-Way ANOVA,
F=4.548, P,0.05) on brain activation. However, post-hoc tests
failed to demonstrate further significant interactions between the
groups. In addition, the data demonstrated a similar maximum
signal intensity change between the CORT and CHOL groups for
both the 40 and 60 mmHg pressures of luminal distension. A
typical time curve of fMRI signal intensity of all activated areas is
shown in Figure 5.
Specific Brain Nuclei Activated in Response to CRD in
Rats with Elevated Levels of Amygdala CORT
In view of our initial observation of a greater increase in total
brain activation in response to CRD in rats with elevated
amygdala CORT for 7 days, we attempted to systematically
examine specific brain nuclei that showed activation in CORT-
treated rats but not in CHOL-implanted rats to gain a more
complete picture of the central nuclei activated by CRD in the 2
groups. We focused our analysis to structures identified by fMRI as
activated in response to 40 mmHg CRD in CORT-implanted rats
but not activated in CHOL controls as these brain sites may be
pivotal for the sensitization of visceral responses (Table 1 and 2).
Of particular interest, we found that areas involved in the
Figure 1. Histological appearance of the colonic mucosa from
rats in which the balloon catheter was distended for 8 cycles
‘on’ and 8 cycles ‘off’ at 40 and 60 mmHg. A), C) and E) are from
the proximal, medial and distal colon, respectively, of naı ¨ve rats. B), D)
and F) are from the proximal, medial and distal colon, respectively, of
rats that underwent the distention protocol. All slides are at 646and
the black bar represents 0.5 mm.
doi:10.1371/journal.pone.0008573.g001
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CORT-implanted animals but no activation in CHOL-implanted
controls. In CORT implanted rats, the 40 mmHg visceral stimulus
activated specific limbic structures including the hippocampal
complex and the hypothalamus. Additionally, brain regions that
form descending efferent pathways such as the basal ganglia
exhibited activation in MRI signal in CORT but not CHOL-
treated rats in response to 40 mmHg. CORT-treated rats also
displayed activation in the sensory processing areas such as the
somatosensory cortex during the 40 mmHg CRD that were not
activated at the same distension pressure in CHOL controls
(Figure 6A–B). As illustrated in figure 6C–D we show the nuclei
that were activated at 60 mmHg CRD following amygdala
CORT treatment but showed no activation in response the same
stimuli in CHOL-treated rats. In response to 60 mmHg animals
receiving CORT showed activated pixels in limbic areas such as
the cingulate cortex and sensory integration areas including the
thalamus. Additionally, brainstem structures involved in sensory-
motor integration including the pontine and reticular nuclei also
showed activation in response to 60 mmHg CRD in CORT-
treated animals but not CHOL controls (Table 1 and 2).
Our final analysis examined specific central sites that were not
activated in response to CRD at 40 mmHg but showed activation
at the higher distension pressure of 60 mmHg in both CHOL and
CORT treated rats (Table 1 and 2). This analysis demonstrated
that the amygdala, hippocampus and hypothalamus, important
regulators of autonomic and neuroendocrine function, showed
activation only at 60 mmHg in CHOL-treated rats (Figure 7A–B).
The pontine nuclei and thalamus showed activation at 60 mmHg
but not 40 mmHg in CORT-implanted animals (Figure 7C–D).
Interestingly, in CORT-treated rats, 60 mmHg distension also
correlated with increased activation of the raphe nuclei which
regulate serotonergic activity in the CNS.
Discussion
Stress and anxiety alter visceral perception and may play a role
in central pain amplification and the pathophysiology of IBS [15].
The current study used fMRI to identify areas of brain activation
in response to distension of the colorectum. Specifically we
investigated brain activation in response to CRD between rats
with bilateral amygdala implants of CORT and age and weight-
matched CHOL control rats. We provide evidence that elevated
CORT on the amygdala significantly increases brain activation in
response to CRD compared to that seen in CHOL-treated
controls. Taken together the results of the present study support
our hypothesis that exposure of the amygdala to elevated levels of
CORT leads to colonic hypersensitivity via enhanced activation of
specific central circuitry. Specifically, we showed that fMRI detects
areas of the brain activated by CRD. In the current study we were
able to show CNS activation in the CORT-treated animals in
response to distension pressure (40 and 60 mm Hg) was
significantly greater than that in CHOL controls. In light of the
recent findings by Lazovic et. al. [30], also in anesthetized rats,
where 40 mmHg distension pressures did not produce a significant
activation of the brain, we opted not to attempt lower distensions
pressures. The reason for the depressed threshold in the neuronal
activation in response to CRD between the two studies is unknown
but is unlikely to be related to the level of anesthesia since in both
studies the rats were anesthetized with chloral hydrate. Another
possible explanation may be related to the resolution of the images
since we used a 7T magnet whereas the earlier study employed a
3T magnet. In the current study, the highest distension pressure
that we employed was 60 mmHg, and we did not investigate CNS
Figure 2. Localization of the micropellets. A) Adapted coronal
diagrams from Paxinos and Watson [55] with the amygdala shaded. All
micropellets (CHOL - white circles; CORT - black triangles) were on the
dorsal margin of the amygdala between 1.80 and 3.14 mm caudal to
bregma. B) Representative RARE images from a typical experiment
showing the location of the micropellet over the dorsal margin of the
amygdala. Distance is relative to bregma and the white arrows indicate
the end of the cannula.
doi:10.1371/journal.pone.0008573.g002
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PLoS ONE | www.plosone.org 3 January 2010 | Volume 5 | Issue 1 | e8573Figure 3. Total brain activation at 40 mmHg CRD. A) Activation in all rats with CHOL-containing micropellets. B) Activation in all rats with
CORT-containing micropellets. For both A) and B), the total number of pixels per slice is shown in the histogram below the slice. The scale for r (0.4,
blue to 0.7, red) is also provided. As illustrated, there was greater activation in rats with CORT micropellets in each slice.
doi:10.1371/journal.pone.0008573.g003
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PLoS ONE | www.plosone.org 4 January 2010 | Volume 5 | Issue 1 | e8573Figure 4. Total brain activation at 60 mmHg CRD. A) Activation in all rats with CHOL-containing micropellets. B) Activation in all rats with
CORT-containing micropellets. For both A) and B), the total number of pixels per slice is shown in the histogram below the slice. The scale for r (0.4,
blue to 0.7, red) is also provided. As illustrated, there was greater activation in rats with CORT micropellets in each slice.
doi:10.1371/journal.pone.0008573.g004
fMRI of Colon Hypersensitivity
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have been some reports that this level of CRD leads to
sensitization of a visceromotor behavioral response, indicative of
colorectal hypersensitivity that may be related to a local
inflammatory response due to mucosal damage [35]. We found
in the current study that repetitive CRD at 40 and 60 mmHg does
not induce damage to the colonic mucosa thus eliminating the
possibility that peripheral afferent sensitization was responsible for
the enhanced brain activation.
A significant advance made in the current study was the
enhanced brain activation in response to CRD in rats with
CORT-containing micropellets placed stereotaxically on the
dorsal margin of the amygdala. Thus, when taken together, we
believe that this study provides pivotal data supporting the
hypothesis that the amygdala is an important nucleus for the
sensitization of neuronal sensory circuits that are involved in the
induction of colonic hypersensitivity. The findings from the
current study demonstrate a positive BOLD signal change in
specific brain regions in response to elevated levels of CORT on
the amygdala. Despite the size of the rat brain compared the
human brain the use of a 7T magnet allowed us to distinguish
specific brain nuclei but not sub-nuclei within that structure as
seen with techniques such as c-fos and 2-deoxyglucose [36]. Here
we show that CRD activated specific nuclei in both the CORT
and CHOL controls. These areas include a collection of cortical
Figure 5. Change in signal intensity with CRD. The solid line
represents the averaged fMRI signal intensity over the time-course of
the distension paradigm (dashed-line represents deflation or inflation
state of the colorectal balloon) for a typical experiment. As shown there
is a rapid increase in signal intensity with balloon inflation indicating
that the activated areas are due to the colonic stimulus.
doi:10.1371/journal.pone.0008573.g005
Table 1. Nuclei activated in ventral axial slices 1–4 (Bregma
29.6–26.0 mm).
Distension Pressure 40 mmHg 60 mmHg
Nuclei CHOL CORT CHOL CORT
Amygdala 0.560.5 5.563.5 10.064.0 6.764.6
Basal Ganglia NA 6.563.1 3.562.2 6.562.7
Cerebellum*
{ NA 20.269.2 20.8610.8 37.3616.0
Cochlear Nuclei* NA 0.560.3 NA 2.861.6
Ectorhinal Cortex* NA 0.860.5 NA 5.062.7
Entorhinal Cortex NA 3.061.4 3.061.8 4.864.1
Facial Nucleus 0.560.5 0.760.4 0.360.3 1.760.9
Hippocampus 1.061.0 5.362.8 13.768.8 21.7610.1
Hypothalamus 2.561.6 2.761.1 10.365.9 11.265.1
Inferior Colliculus* NA 0.360.3 0.260.2 1.360.5
Insular Cortex NA 2.261.0 0.560.5 3.262.6
Internal Capsule NA 0.260.2 0.260.2 1.761.1
Lateral Lemniscus NA 0.360.3 1.261.2 2.762.1
Olfactory Nuclei 0.360.3 2.062.0 0.760.5 2.361.5
Perirhinal Cortex* NA 4.262.0 0.760.7 5.762.6
Piriform Cortex NA 0.860.8 1.761.7 2.762.5
Pontine Nuclei 0.360.3 3.061.8 3.363.0 9.264.7
Raphe Nuclei 0.760.7 0.360.3 2.261.4 3.561.6
Reticular Nuclei 0.560.5 6.563.2 6.3+4.1 14.267.1
Somatosensory Cortex NA 0.360.3 NA 1.360.7
Tegmental Nuclei 0.860.8 1.761.1 1.260.8 6.062.5
Temporal Assoc. Cortex NA NA NA 4.362.7
Thalamus NA 0.560.5 1.761.3 2.761.8
Trigeminal Nuclei 1.060.7 3.861.9 3.762.4 5.762.9
Values listed are mean6SEM for pixels with r$0.4, n=6/group. NA=no
activation.
*P,0.05 between groups.
{P,0.05, between pressures, 2-way ANOVA.
doi:10.1371/journal.pone.0008573.t001
Table 2. Nuclei activated in dorsal axial slices 5–8 (Bregma
24.8–21.2 mm).
Distension Pressure 40 mmHg 60 mmHg
Nuclei CHOL CORT CHOL CORT
Basal Ganglia 1.261.2 0.860.5 3.562.9 2.761.6
Cerebellum 8.065.2 39.3618.6 29.8613.4 53.5618.4
Cingulate Cortex 0.860.8 4.262.5 1.861.3 4.562.2
Corpus Callosum NA 1.761.7 NA 3.262.4
Ectorhinal Cortex NA 5.763.3 4.261.9 7.563.5
Entorhinal Cortex NA 10.264.3 6.063.3 6.062.9
Habenular Nucleus NA 2.061.3 1.061.0 1.060.7
Hippocampus 0.760.7 17.7611.6 7.564.5 17.767.8
Inferior Colliculus 0.360.3 4.562.1 1.761.7 3.561.7
Insular Cortex NA NA 0.360.3 0.260.2
Internal Capsule 0.360.3 NA 0.760.4 NA
Motor Cortex* 0.560.5 1.860.7 0.260.2 2.260.7
Orbitofrontal Cortex NA NA NA 2.361.7
Perirhinal Cortex NA 8.563.4 7.363.9 7.863.0
Prelimbic Cortex NA 1.261.2 NA 2.761.7
Pretectal Nucleus NA 0.560.5 2.562.0 2.061.4
Retrosplenial Cortex 8.265.2 18.367.7 11.563.7 12.064.2
Septal Nucleus NA 2.862.5 NA 1.561.1
Somatosensory Cortex* NA 4.361.7 3.562.6 6.562.1
Superior Colliculus*
{ NA 2.061.6 0.760.7 8.362.5
Temporal Assoc. Cortex NA 2.061.4 1.861.2 4.561.9
Thalamus NA 3.061.7 4.062.5 3.561.6
Values listed are mean6SEM for pixels with r$0.4, n=6/group. NA=no
activation.
*P,0.05 between groups.
{P,0.05, between pressures, 2-way ANOVA.
doi:10.1371/journal.pone.0008573.t002
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studies as the pain matrix. This central network includes the
thalamus, amygdala, cingulate cortex, basal ganglia, cerebellum
and somatosensory cortex [37–39]. The current study demon-
strates that, not only does luminal distension activate these
structures in rodents, but also that CORT administration leads to
a greater increase in the activation of these structures as well as the
recruitment of other brain areas that were not activated in CHOL
controls. A specific brain area activated in our study with
particular relevance to visceral sensitivity is the hypothalamus
which is known to be involved in emotional expression and the
regulation of behavioral, neuroendocrine, and autonomic func-
tions; however, this structure also contains visceral motor areas
and plays an important role in modulating ascending nociceptive
transmission. Specifically, the hypothalamus has diffuse connec-
tions to brainstem areas regulating visceral pain processing
including the periaqueductal gray, raphe nuclei, and locus
coeruleus [40]. Another structure important for visceral sensory
processing is the cingulate cortex, which is involved in the
awareness and perception of internal bodily states and contains
specific subareas for integrating visceral sensation [41]. The
cingulate also has direct connections to the amygdala, periaque-
ductal grey, and orbitofrontal cortex [42]. Taken together our
observations in rodents [32,34] support clinical observations in
which abnormalities in amygdala activation appear common in
IBS patients [24]. In the current study negative BOLD signal
changes have not been analyzed since the interpretation of
deactivation remains rather controversial, however they represent
an area for future research investigation in the current animal
model.
Although real-time fMRI has been reported in conscious rats by
the team of Ferris and co-workers [43–45] who acclimated rats to
the experimental conditions within the fMRI magnet as
demonstrated by a reduction in the elevation in plasma CORT
and motor movements, many technical and ethical challenges exist
in performing experiments in unanesthetized rats using our
experimental paradigm. To perform CRD in awake rats, they
must be restrained in the fMRI magnet which is problematic in
Fischer-344 (F344) rats for two important reasons: firstly there is a
strong relationship between stress and the stimulation of visceral
hypersensitivity in response to the stress provoking situations, and
secondly F344 rats display a vulnerability to repeated stress since
they do not habituate to the stressor whereas Sprague Dawley rats
show a gradual decrease in the HPA axis following repeated
Figure 6. Specific nuclei activated in rats with CORT micropel-
lets but not activated in rats with CHOL micropellets by
40 mmHg or 60 mmHg CRD. Illustrated data is from an individual
rat representative of the median activation for either CORT (A and C) or
CHOL (B and D). In the CORT treated rat, specific nuclei showing
activation by CRD at 40 mmHg include the hypothalamus (HYPO), basal
ganglia (BG), hippocampal complex (HIPP) and somatosensory cortex
(SSC). In CORT-treated rat, specific nuclei showing activation by CRD at
60 mmHg include reticular nuclei (RET), pontine nuclei (PONT),
thalamus (THAL) and the cingulate cortex (CC). The scale for r (0.4,
blue to 0.7, red) is also provided.
doi:10.1371/journal.pone.0008573.g006
Figure 7. Specific nuclei activated by 60 mmHg CRD but not at
40 mmHg CRD in rats with either CORT or CHOL micropellets.
Illustrated data is from an individual rat representative of the median
activation. In the CHOL (A - 60 mmHg, B - 40 mmHg) treated rat,
specific nuclei showing activation by CRD only at 60 mmHg include the
hypothalamus (HYPO), the amygdala (AMYG) and hippocampal
complex (HIPP). In the CORT (C – 60 mmHg, D – 40 mmHg) treated
rat, specific nuclei showing activation by CRD only at 60 mmHg include
the raphe (RAPH), pontine nuclei (PONT) and thalamus (THAL). The scale
for r (0.4, blue to 0.7, red) is also provided.
doi:10.1371/journal.pone.0008573.g007
fMRI of Colon Hypersensitivity
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performed experiments in anesthetized animals, and given the
robust nature of the BOLD signal intensity in our anesthetized
animals in response to CRD we consider that studies on awake,
restrained rats will likely yield data that is confounded by the
effects of motion artifact during the distension procedure, stress
due to the restraint and the inability to habituate F344 to the
stressor. Recent studies claimed to have performed functional
brain activation in unrestrained conscious rats in response to CRD
[47], however the results from these studies must be treated with
caution. Specifically, a limitation in the interpretation of these
studies is that although [
14C]-iodoantipyrine was injected after the
onset of CRD in the conscious rats, the brain images were taken
from autoradiographic analysis from the same animals following
euthanization, which may have had an effect on the distribution of
this marker. In the current study our experimental procedure of
performing real-time imaging rather than post-mortem analysis of
brain slices offers many significant and obvious advantages,
however there are factors that may affect interpretation of our
findings including potential changes in cerebral metabolism and
blood flow due to the anesthetic that is required to avoid
movement artifacts. Moreover, BOLD imaging is not a direct
measure of neuronal activity; instead a measure of oxygen
utilization, which we assume correlates with metabolic activity.
We consider our findings with 40 mmHg to have produced
some pivotal data related to the central sites that may be involved
in central sensitization despite the absence of data using lower
distension pressures. However, in our model it is important to
mention that central disinhibition of afferent signaling can also
occur which would result in the same ‘hypersensitive’ response.
Furthermore, a limitation of the current study is that although our
study provides objective data for the existence of neuronal
hypersensitivity, the structure-function relationship of these
activated regions was beyond the scope of the current study.
There are a number of important aspects of our model that
support the validity of our conclusions. The first relates to the
specificity of the observed responses to the amygdala. Although the
micropellet was placed stereotaxically on the dorsal margin of the
amygdala and ensures that the CORT bathes the central
amygdala without physical damage to the structure, the possibility
exists that other areas adjacent to the amygdala that express
steroid receptors such as the hippocampus and caudate putamen,
could be involved in our responses due to spread of the CORT
from the micropellet. However, in our previous study we
systematically performed a series of ‘off-site’ controls to examine
the effect of elevated CORT in areas adjacent to the amygdala
and found that the effects were specific to the central amygdala
and not due to diffusion to adjacent brain regions [32].
Furthermore, to substantiate our claim that the steroid micropellet
remained confined to the area of the implant, others have shown a
diffusion distance of 750 mm for a 30 mg micropellet [19] and
900 mm for a 150 mg cannula of CORT [48]. Moreover, although
there is a close relationship between the amygdala and the
ventrocaudal caudate putamen, previous studies using autoradi-
ography have shown limited binding of CORT [49], due to
minimal expression of GR with no appreciable MR in the
ventrocaudal caudate putamen [50]. Finally, although CRD can
trigger contraction of the anal sphincter, and contraction of this
sphincter also induces brain fMRI activity, in the current study
external anal sphincter contraction was not measured but the level
of fMRI activity was likely identical in both CORT and CHOL-
treated rats in response to CRD.
In conclusion, the present study provides evidence of increased
brain activation, measured as increased MRI signal, in response to
CRD in rats, following exposure of the amygdala to elevated levels
of CORT for 7 days. Our findings demonstrate that CRD lead to
activation of the brain in specific regions known to be involved in
somatosensory processing, and that exaggerated brain activation
in CORT-implanted animals is suggestive of heightened sensitivity
of the brain-gut axis in response to modulation of the amygdala. In
light of data from IBS patients demonstrating increased activation
in many of the same brain regions that we have observed in the
current study, we speculate that our findings in a rodent model
may imply that abnormal amygdala activity is a key component to
enhanced brain activation involved in the development of anxiety
and gut hypersensitivity in IBS.
Materials and Methods
Ethics Statement
All experiments were in compliance with the National Institute
of Health Guide for Care and Use of Laboratory Animals and the
International Association for the Study of Pain Research
Guidelines. The Animal Care and Use Subcommittee at both
the Oklahoma City Veterans Affairs Medical Center and the
Oklahoma Medical Research Foundation approved all the
experimental procedures.
Animals
Experiments were performed on male F344 rats weighing 250–
310 g and 13–15 wk of age purchased from Charles River
Laboratories (Wilmington, MA) and housed under standard
conditions with 12-h light/dark cycle with unrestricted access to
chow and water. Rats remained in the animal facility for at least 7
days before the experimental procedure, and all experiments were
performed at the same time each day. Experiments were
performed in a total of 6 rats per experimental group (CORT
40 and 60 mmHg; CHOL 40 and 60 mmHg). A sample size of 6
in each group was determined to have 90% power to detect the
expected difference between means (two group Satterthwaite t-test
with a 0.05 two-sided significance level) [32].
Stereotaxic Surgery
Animals had micropellets (30 mg - diameter of 0.3 mm with a
height of 1.0 mm) of either CORT or CHOL placed bilaterally on
the dorsal margin of the CeA under ketamine (100 mg/kg
intraperitoneal (IP)) and xylazine (10 mg/kg IP) anesthesia as
previously described [32,34]. Animals were then allowed seven
days for recovery, during which time their behavior was observed
to ensure that they were not in distress.
Localization of Stereotaxic Implant
During the imaging protocol, high-resolution anatomical images
(RARE imaging sequence, field of view 2.462.4 cm
2, matrix size
2566256) were obtained to illustrate the position of the
micropellets of CORT or CHOL, as shown in Figure 2B.
Following the imaging protocol, animals were euthanized and
brains rapidly removed and frozen in chilled 2-methylbutane
(Fisher Scientific, Fair Lawn, NJ). Brains were then stored at
280uC until cryosectioning. Serial coronal cross-sections (50 mm)
were cryosectioned (Bright OTF, Fairfield, NJ) at 220uC and
mounted onto slides followed by verification of micropellet
placement by light microscopy.
Colorectal Distension
A 5-cm latex balloon catheter was constructed as described
previously [32]. The balloon was then inserted via the anal canal
8 cm into the colon and secured with surgical tape around the tail
fMRI of Colon Hypersensitivity
PLoS ONE | www.plosone.org 8 January 2010 | Volume 5 | Issue 1 | e8573following choral hydrate anesthesia. CRD was performed by
inflating the balloon using a constant pressure barostat (Model
IIR, G&J Electronics, Toronto, Canada) synchronized to the
fMRI magnet. A series of 8 phasic CRD was performed at
distension pressures of 40 mmHg and then 8 phasic CRD at
60 mmHg for 30 s each (‘on’) with a 90 s deflation (0 mmHg –
‘off’) between distension periods.
Histology
To determine whether CRD had any effect on the colonic
mucosa, we performed the identical distension protocol in a
subgroup of rats (n=3). Naive rats (n=3) in which a balloon was
neither inserted nor distended served as controls. Three 1 cm
tissue segments from each rat were collected from the proximal
(1 cm distal to cecum), medial (8 cm proximal to rectum) and
distal (2 cm proximal to rectum) colon. Tissues were fixed in 4%
buffered formalin, processed, embedded in paraffin and sectioned
at 5 mm thickness. They were stained with haematoxylin and eosin
and assessed for inflammation by a blinded observer under a light
microscope. Inflammatory parameters were scored using the
following criteria: 0–2 for ulceration and fibrosis and 0–3 for
inflammatory infiltration and depth of lesion [51]. A score of 0
designated no visible signs of pathology in the tissue.
Functional Magnetic Resonance Imaging
Imaging was performed on a 7T Bruker MRI spectrometer
(Biospec, Bruker Biospin, Billerica, MA) with a gradient coil (S116,
Bruker Biospin). Prior to imaging, rats were anesthetized with
chloral hydrate (400 mg/kg IP). To ensure a similar level of
anesthesia across animals and within the same animal during the
course of a single experiment an IP Teflon catheter (BD Insyte
Autoguard, BD Medical Systems, Sandy, UT) was attached to an
injection line for delivering additional anesthetic (40 mg/kg) if
indicated by an increase in respiration rate by more than 20
breaths/min from the start of the experiment via monitoring
respiration on a monitor (Model 1025, SA Instruments, Inc., Stony
Brook, NY) via a transducer placed under the rat. The balloon
catheter was then inserted and attached to the barostat with tygon
tubing (4/160 ID, 5/160 OD). Following balloon catheter
insertion, the rats were placed in a positioning frame and in the
imaging coil (receive only quadrature surface coil and multirung
volume coil for excitation). The barostat was interfaced to the
MRI system console (MRI Interface, G & J Electronics, Inc.) to
synchronize distention and deflation cycles with image acquisition.
The fMRI paradigm consisted of 8 inflation and deflation cycles
consisting of a 90 s baseline period with the balloon deflated (‘off’),
during which time 9 images were acquired, followed by a 30 s
activation or inflation period (‘on’), during which 3 images were
obtained, for a total of 16 min and 96 images for each pressure (40
or 60 mmHg). The desired pressure of CRD was achieved by
rapidly inflating (,5 s) the balloon controlled by the barostat.
fMRI Image Selection
To minimize signal loss due to susceptibility artifacts at air-tissue
interfaces (sinus cavities), the axial plane was chosen. Eight axial
(1.2 mm thick) slices were positioned relative to bregma at the
following dorsoventral distances: 29.6, 28.4, 27.2, 26.0, 24.8,
23.6, 22.4 and 21.2 mm. Anatomical T2-weighted images
(effective TE/TR=50.78/2500 ms, field of view 464c m
2, matrix
size 1286128, 8 averages) were acquired in 5.3 min using the
rapid acquisition with relaxation enhancement imagining se-
quence. Functional images were obtained using a T2
*-weighted
FLASH (effective TE/TR=14/160 ms, 64664 matrix, 1 average)
10.24 s for one image, with the same slice position, slice thickness,
and field of view as the anatomical images.
Data and Statistical Analysis
Post processing and analysis of fMRI data were performed using
the CCHIPS software [52]. Image co-registration and motion
corrections were achieved with a pyramid co-registration algo-
rithm [53]. Areas of activation in different regions acquired during
8 ‘off’ cycles and 8 ‘on’ cycles was cross-correlated with an
idealized wave representative of the stimulation paradigm [54]. A
cross-correlation coefficient (r) value of the pixels higher than
r$0.4 is considered statistically significant (corresponding to
P,0.0001), and is shown as different color-coded pixels repre-
senting activation on the image. Brain areas that contained
activated pixels were identified based on a stereotaxic atlas [55],
i.e. images were overlaid with the neuroanatomical image for
nuclei identification. Total numbers of activated pixels for brain
structures that extended over more than one slice were determined
by adding activated pixels per each slice. Total brain activation in
CORT and CHOL-treated animals was assessed at each pressure
in terms of the total number of activated pixels per animal. Since a
Bartlett’s test for variance indicated a significant difference in
variance between groups, to compare total brain activation
between the CORT and CHOL groups in different brain nuclei,
the total pixels per nuclei were logarithmically transformed (with
no activation treated as 0). The transformed data was then
subjected to a two-way analysis of variance (ANOVA) (group and
pressure) followed by a Bonferroni post-hoc analysis (GraphPad
Prism v. 4.0c for Mac, San Deigo, CA). The non-transformed data
for individual nuclei were expressed as mean6standard error of
the mean (SEM).
Drugs and Chemicals
CHOL, CORT and choral hydrate were obtained from Sigma-
Aldrich (St. Louis, MO). CHOL and CORT were placed in the
brain as micropellets of the dry powder of the chemical. Choral
hydrate was dissolved in sterile saline to a concentration of
100 mg/mL (wt/vol). Ketamine (100 mg/mL vial) was obtained
from Phoenix Pharmaceutical (St. Joseph, MO) and administered
in combination with xylazine (20 mg/mL vial) acquired from
Hospira (Lake Forest, IL).
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